Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29726 - 29750 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Decitabine	Approved Investigational	MT1X	4501	upregulated	decitabine results in increased expression of MT1X mRNA	16q13	A21912
Decitabine	Approved Investigational	MT2A	4502	upregulated	decitabine results in increased expression of MT2A mRNA	16q13	A21912
Decitabine	Approved Investigational	MT3	4504	upregulated	decitabine results in increased expression of MT3 mRNA	16q13	A21999
Decitabine	Approved Investigational	MTMR6	9107	upregulated	decitabine results in increased expression of MTMR6 mRNA	13q12.13	A21912
Decitabine	Approved Investigational	MTRF1L	54516	upregulated	decitabine results in increased expression of MTRF1L mRNA	6q25.2	A20985
Decitabine	Approved Investigational	MTSS1	9788	upregulated	decitabine results in increased expression of MTSS1 mRNA	8q24.13	A21919
Decitabine	Approved Investigational	MUC4	4585	upregulated	decitabine results in increased expression of MUC4 mRNA	3q29	A22000
Decitabine	Approved Investigational	MX1	4599	upregulated	decitabine results in increased expression of MX1 mRNA	21q22.3	A21919 A21915
Decitabine	Approved Investigational	MYC	4609	downregulated	decitabine results in decreased expression of MYC mRNA	8q24.21	A21978
Decitabine	Approved Investigational	MYC	4609	upregulated	decitabine results in increased expression of MYC mRNA	8q24.21	A21004
Decitabine	Approved Investigational	MYCNOS	10408	downregulated	decitabine results in decreased expression of MYCNOS mRNA	2p24.3	A21197
Decitabine	Approved Investigational	MYL7	58498	upregulated	decitabine results in increased expression of MYL7 mRNA	7p13	A22001
Decitabine	Approved Investigational	MYO18A	399687	downregulated	decitabine results in decreased expression of MYO18A mRNA	17q11.2	A21913
Decitabine	Approved Investigational	MYO1F	4542	upregulated	decitabine results in increased expression of MYO1F mRNA	19p13.2	A20985
Decitabine	Approved Investigational	NANOG	79923	downregulated	decitabine results in decreased expression of NANOG mRNA	12p13.31	A21978
Decitabine	Approved Investigational	NCK1	4690	upregulated	decitabine results in increased expression of NCK1 mRNA	3q22.3	A21321
Decitabine	Approved Investigational	NCS1	23413	upregulated	decitabine results in increased expression of NCS1 mRNA	9q34.11	A21917
Decitabine	Approved Investigational	NDN	4692	upregulated	decitabine results in increased expression of NDN mRNA	15q11.2	A21915
Decitabine	Approved Investigational	NDRG1	10397	upregulated	decitabine results in increased expression of NDRG1 mRNA	8q24.22	A21917
Decitabine	Approved Investigational	NDUFA7	4701	downregulated	decitabine results in decreased expression of NDUFA7 mRNA	19p13.2	A20985
Decitabine	Approved Investigational	NDUFS8	4728	upregulated	decitabine results in increased expression of NDUFS8 mRNA	11q13.2	A22002
Decitabine	Approved Investigational	NEDD4L	23327	downregulated	decitabine results in decreased expression of NEDD4L mRNA	18q21.31	A21913
Decitabine	Approved Investigational	NEK2	4751	downregulated	decitabine results in decreased expression of NEK2 mRNA	1q32.3	A21913
Decitabine	Approved Investigational	NETO1	81832	upregulated	decitabine results in increased expression of NETO1 mRNA	18q22.3	A21915
Decitabine	Approved Investigational	NFATC1	4772	downregulated	decitabine results in decreased expression of NFATC1 mRNA	18q23	A21930

Displaying entries 29726 - 29750 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability